Dynamics of diabetes and obesity: Epidemiological perspective

被引:175
作者
Boles, Annette [1 ]
Kandimalla, Ramesh [2 ]
Reddy, P. Hemachandra [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Community Outreach & Educ, 6630 S Quaker Ave,Suite E, Lubbock, TX 79413 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Garrison Inst Aging, 3601 4th St,MS 9424, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA
[4] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3601 4th St, Lubbock, TX 79430 USA
[5] Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, 3601 4th St, Lubbock, TX 79430 USA
[6] Texas Tech Univ, Hlth Sci Ctr, Speech Dept, 3601 4th St, Lubbock, TX 79430 USA
[7] Texas Tech Univ, Hlth Sci Ctr, Language & Hearing Sci Dept, 3601 4th St, Lubbock, TX 79430 USA
[8] Dept Publ Hlth, 3601 4th St,MS 9424, Lubbock, TX 79430 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2017年 / 1863卷 / 05期
关键词
Alzheimer's disease; Diabetes; Obesity; FTO; CARDIOVASCULAR RISK-FACTORS; STIFF-MAN SYNDROME; NUTRITION THERAPY RECOMMENDATIONS; GLYCOGEN-SYNTHASE KINASE-3; KLINEFELTERS-SYNDROME; INSULIN-RESISTANCE; SELF-MANAGEMENT; ANTIVIRAL ANTIBODIES; ALZHEIMERS-DISEASE; METABOLIC SYNDROME;
D O I
10.1016/j.bbadis.2017.01.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this review article is to understand the current literature on obesity, diabetes and therapeutic avenues across the world. Diabetes is a chronic lifestyle condition that affects millions of people worldwide and it is a major health concern in our society. Diabetes and obesity are associated with various conditions, including non modifiable and modifiable risk factors. Early detectable markers are not well established to detect pre-diabetes and as a result, it becomes diabetes. Several published epidemiological studies were assessed and the findings were summarized. Resources from published studies were used to identify criteria used for pre-diabetes, the role of diet in pre-diabetics and potential risks and characteristics associated with pre-diabetes. Preventive strategies are needed to combat diabetes. Individuals diagnosed with pre-diabetes need detailed education, need to fully understand the risk factors and have the ability to manage diabetes. Interventions exist that include chronic disease self-management programs, lifestyle interventions and pharmacological strategies. Obesity plays a large role in causing pre-diabetes and diabetes. Critical analysis of existing epidemiological research data suggests that additional research is needed to determine the efficacy of interventions. This article is part of a Special Issue entitled: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases edited by P. Hemachandra Reddy. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:1026 / 1036
页数:11
相关论文
共 128 条
  • [1] Diabetes in Pregnancy and Childhood Cognitive Development: A Systematic Review
    Adane, Akilew Awoke
    Mishra, Gita D.
    Tooth, Leigh R.
    [J]. PEDIATRICS, 2016, 137 (05)
  • [2] Lifestyle Interaction With Fat Mass and Obesity-Associated (FTO) Genotype and Risk of Obesity in Apparently Healthy US Women
    Ahmad, Tariq
    Lee, I-Min
    Pare, Guillaume
    Chasman, Daniel I.
    Rose, Lynda
    Ridker, Paul M.
    Mora, Samia
    [J]. DIABETES CARE, 2011, 34 (03) : 675 - 680
  • [3] Alam F., 2016, CURR PHARM DES
  • [4] Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc14-S081, 10.2337/dc13-S011]
  • [5] Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI [10.2337/dc19-S002, 10.2337/dc18-S002, 10.2337/dc09-S062, 10.2337/dc12-S064]
  • [6] [Anonymous], 2014, DIABETES CARE S1
  • [7] [Anonymous], 2015, J ALZHEIMERS DIS PAR, DOI 10.4172/2161-0460.1000193
  • [8] Sex differences in cardiovascular risk factors and disease prevention
    Appelman, Yolande
    van Rijn, Bas B.
    ten Haaf, Monique E.
    Boersma, Eric
    Peters, Sanne A. E.
    [J]. ATHEROSCLEROSIS, 2015, 241 (01) : 211 - 218
  • [9] Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
    Astrup, A.
    Carraro, R.
    Finer, N.
    Harper, A.
    Kunesova, M.
    Lean, M. E. J.
    Niskanen, L.
    Rasmussen, M. F.
    Rissanen, A.
    Rossner, S.
    Savolainen, M. J.
    Van Gaal, L.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (06) : 843 - 854
  • [10] ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428